A recent study shows that orphan nuclear receptor TLX leads to immunosuppression via transcriptional activation of PD-L1 binding to PD-1 on tumor-infiltrating lymphocytes and tumor-associated macrophages in glioma [27]. This evidence concerns the gene CD274 and central nervous system cancer.